This modification to a delivery order under an Environmental Protection Agency indefinite delivery contract authorizes administrative changes to the contract administration team, specifically updating the contracting officer, contract specialist, and local clause EPA-G-42-101 representatives. The underlying delivery order, valued at $287,350.08 on a firm fixed-price basis, supports rescreening of core reference chemicals in estrogen receptor and androgen receptor binding assays. The work is performed by Eurofins Discovery Services North America, LLC, a specialized contract research organization headquartered in St. Charles, Missouri, with an ultimate completion date of August 24, 2026. This award does not utilize a small business set-aside designation.
Eurofins Discovery Services North America, LLC is a foreign-owned, for-profit research organization with established expertise in receptor binding studies, toxicology testing, and analytical chemistry services. The company maintains a substantial federal contract portfolio spanning multiple agencies, including the EPA, National Institutes of Health components, Food and Drug Administration, and National Institute on Drug Abuse, with four active indefinite delivery vehicles representing combined ceiling values exceeding $84.9 million. The EPA's Office of Chemical Safety and Pollution Prevention has leveraged Eurofins' capabilities through a $9.7 million single-award IDV for in vitro and target-based assays, which extends through December 2026 and has supported multiple delivery orders for confirmatory assays and chemical mechanism of action research aligned with the agency's chemical safety evaluation mission.
Generated 4/2/26, 8:17 AM